Methyl 4,4-dimethyl-3-oxopentanoate

Catalog No.: 
ACJEDU305
CAS No.: 
55107-14-7
Molecular Formula: 
C8H14O3
Molecular Weight: 
158.20
Methyl 4,4-dimethyl-3-oxopentanoate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100g98%$120.00In stockIn stock
500g98%$443.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 4,4-dimethyl-3-oxopentanoate
IUPAC Namemethyl 4,4-dimethyl-3-oxopentanoate
MDL No.MFCD00008847
Molecular FormulaC8H14O3
Molecular Weight158.20
SMILESCC(C)(C)C(CC(OC)=O)=O
InChI KeyXTXCFTMJPRXBBC-UHFFFAOYSA-N
Synonym1,1-Cyclopropanedicarboxamide, N-[4-[[2-[(cyclopropylcarbonyl)amino]-4-pyridinyl]oxy]-2,5-difluorophenyl]-N'-(4-fluorophenyl)- | PdCl2(dppf)2 DCM | Pivaloylacetic Acid Methyl Ester | F0001-1446 | EN300-21400 | METHYL-4,4-DIMETHYL-3-OXOPENTANOATE | Methylp
CAS No.55107-14-7
PubChem CID99597

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H227-H315-H319-H335
Precautionary Statement(s)
P305+P351+P338

Synthetic Route by SureRoute

1. ACJEDU305 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACJEDU305 route product structure diagram
    ACJEDU30555107-14-7In Stock
Inquiry

2. ACJEDU305 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACHUHQ605 route compound structure diagram
    --
  4. Then
  5. ACJEDU305 route product structure diagram
    ACJEDU30555107-14-7In Stock
Inquiry

3. ACJEDU305 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACJEDU305 route product structure diagram
    ACJEDU30555107-14-7In Stock
Inquiry

Comments (0)